Literature DB >> 26806779

Neuroscience of opiates for addiction medicine: From stress-responsive systems to behavior.

Yan Zhou1, Francesco Leri2.   

Abstract

Opiate addiction, similarly to addiction to other psychoactive drugs, is chronic relapsing brain disease caused by drug-induced short-term and long-term neuroadaptations at the molecular, cellular, and behavioral levels. Preclinical research in laboratory animals has found important interactions between opiate exposure and stress-responsive systems. In this review, we will discuss the dysregulation of several stress-responsive systems in opiate addiction: vasopressin and its receptor system, endogenous opioid systems (including proopiomelanocortin/mu opioid receptor and dynorphin/kappa opioid receptor), orexin and its receptor system, and the hypothalamic-pituitary-adrenal axis. A more complete understanding of how opiates alter these stress systems, through further laboratory-based studies, is required to identify novel and effective pharmacological targets for the long-term treatment of heroin addiction.
© 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dynorphin; HPA axis; Heroin addiction; Opioid receptor; Orexin; POMC; Stress; V1b receptor; Vasopressin

Mesh:

Substances:

Year:  2015        PMID: 26806779     DOI: 10.1016/bs.pbr.2015.09.001

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  10 in total

1.  Total hypothalamic volume is reduced in postmortem brains of male heroin addicts.

Authors:  Ulf J Müller; Kolja Schiltz; Christian Mawrin; Henrik Dobrowolny; Thomas Frodl; Hans-Gert Bernstein; Bernhard Bogerts; Kurt Truebner; Johann Steiner
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-05-22       Impact factor: 5.270

Review 2.  Pharmacotherapeutic management of co-morbid alcohol and opioid use.

Authors:  Lauren E Hood; Jonna M Leyrer-Jackson; M Foster Olive
Journal:  Expert Opin Pharmacother       Date:  2020-02-27       Impact factor: 3.889

Review 3.  Involvement of Activated Brain Stress Responsive Systems in Excessive and "Relapse" Alcohol Drinking in Rodent Models: Implications for Therapeutics.

Authors:  Yan Zhou; Mary Jeanne Kreek
Journal:  J Pharmacol Exp Ther       Date:  2018-04-18       Impact factor: 4.030

4.  Stress-Induced Reinstatement of Nicotine Preference Requires Dynorphin/Kappa Opioid Activity in the Basolateral Amygdala.

Authors:  Stephanie K Nygard; Nicholas J Hourguettes; Gabe G Sobczak; William A Carlezon; Michael R Bruchas
Journal:  J Neurosci       Date:  2016-09-21       Impact factor: 6.167

Review 5.  Medications for substance use disorders (SUD): emerging approaches.

Authors:  Eduardo R Butelman; Mary Jeanne Kreek
Journal:  Expert Opin Emerg Drugs       Date:  2017-10-30       Impact factor: 4.191

6.  Co-occurrence of preconception maternal childhood adversity and opioid use during pregnancy: Implications for offspring brain development.

Authors:  Madeleine C Allen; Nora K Moog; Claudia Buss; Elizabeth Yen; Hanna C Gustafsson; Elinor L Sullivan; Alice M Graham
Journal:  Neurotoxicol Teratol       Date:  2021-09-30       Impact factor: 4.071

7.  Hypothesizing that a Pro-Dopaminergic Regulator (KB220z Liquid Variant) can Induce "Dopamine Homeostasis" and Provide Adjunctive Detoxification Benefits in Opiate/Opioid Dependence.

Authors:  Kenneth Blum; Debra Whitney; Lye Fried; Marcelo Febo; Roger L Waite; Eric R Braverman; Kristina Dushaj; Mona Li; John Giordano; Zsolt Demetrovics; Rajendra D Badgaiyan
Journal:  Clin Med Rev Case Rep       Date:  2016-08-16

Review 8.  Targeting opioid receptor signaling in depression: do we need selective κ opioid receptor antagonists?

Authors:  Sarah J Bailey; Stephen M Husbands
Journal:  Neuronal Signal       Date:  2018-05-14

Review 9.  Pain Therapy Guided by Purpose and Perspective in Light of the Opioid Epidemic.

Authors:  Amie L Severino; Arash Shadfar; Joshua K Hakimian; Oliver Crane; Ganeev Singh; Keith Heinzerling; Wendy M Walwyn
Journal:  Front Psychiatry       Date:  2018-04-23       Impact factor: 4.157

10.  The Effects of Perinatal Oxycodone Exposure on Behavioral Outcome in a Rodent Model.

Authors:  Thitinart Sithisarn; Sandra J Legan; Philip M Westgate; Melinda Wilson; Kristen Wellmann; Henrietta S Bada; Susan Barron
Journal:  Front Pediatr       Date:  2017-08-25       Impact factor: 3.418

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.